Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
RecruitingNCT05834478Phase: PHASE3Started 2024-02-20
Summary
This study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)?
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
75 Years
Locations
Emory University Clinical Research NetworkAtlanta, Georgia, United States
Health Sciences Research BuildingAtlanta, Georgia, United States
Rollins School of Public HealthAtlanta, Georgia, United States
12 Executive Park DriveAtlanta, Georgia, United States
Emory UniversityAtlanta, Georgia, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05834478